caffeine has been researched along with Pulmonary Disease, Chronic Obstructive in 3 studies
Pulmonary Disease, Chronic Obstructive: A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Kunisaki, KM | 1 |
Sin, DD | 1 |
Sweeney, D | 1 |
Hollins, F | 1 |
Gomez, E | 1 |
Saunders, R | 1 |
Challiss, RA | 1 |
Brightling, CE | 1 |
Takata, K | 1 |
Saruwatari, J | 1 |
Nakada, N | 1 |
Nakagawa, M | 1 |
Fukuda, K | 1 |
Tanaka, F | 1 |
Takenaka, S | 1 |
Mihara, S | 1 |
Marubayashi, T | 1 |
Nakagawa, K | 1 |
3 other studies available for caffeine and Pulmonary Disease, Chronic Obstructive
Article | Year |
---|---|
Methylxanthines in COPD: yes to caffeine, no to theophylline.
Topics: Caffeine; Humans; Pulmonary Disease, Chronic Obstructive; Theophylline; Xanthines | 2021 |
[Ca2+]i oscillations in ASM: relationship with persistent airflow obstruction in asthma.
Topics: Adult; Aged; Asthma; Biopsy; Caffeine; Calcium Signaling; Case-Control Studies; Female; Forced Expir | 2014 |
Phenotype-genotype analysis of CYP1A2 in Japanese patients receiving oral theophylline therapy.
Topics: Adult; Aged; Aged, 80 and over; Asthma; Bronchodilator Agents; Caffeine; Cytochrome P-450 CYP1A2; De | 2006 |